1. Synthesis of new N-isobutyryl-L-cysteine/MEA conjugates: evaluation of their free radical-scavenging activities and anti-HIV properties in human macrophages.
- Author
-
Smietana M, Clayette P, Mialocq P, Vasseur JJ, and Oiry J
- Subjects
- Anti-HIV Agents chemical synthesis, Anti-HIV Agents pharmacology, Antioxidants chemistry, Cysteamine analogs & derivatives, Cysteamine therapeutic use, Cysteine therapeutic use, Humans, Structure-Activity Relationship, Anti-HIV Agents chemistry, Cysteine analogs & derivatives, Free Radical Scavengers chemistry, Macrophages virology
- Abstract
Four novel N-isobutyryl-L-cysteine/2-mercaptoethylamine (MEA, cysteamine) conjugates have been designed and synthesized. The antioxidant activities of these new series were evaluated by three different free radical scavenging methods (DPPH test, ABTS test, and deoxyribose assay) and their metal binding capacity was evaluated by the ethidium bromide fluorescence binding assay. These results were compared with those obtained with their pro-GSH acetyl analogues recently developed in our laboratory. We observed that most of these compounds exhibit free radical-scavenging activities similar to those of Trolox, but always superior than NAC. While none of these new derivatives had pro-GSH activities, they displayed anti-HIV properties in human monocyte-derived macrophages infected in vitro. The present study demonstrates that these new N-isobutyryl derivatives, which are expected to have a greater bioavailability than their acetyl analogues, may have useful applications in HIV infection in respect to their antioxidant and anti-HIV activities.
- Published
- 2008
- Full Text
- View/download PDF